Moreover, apart from MNA, there are other cancer events that can lead to dysregulated N-Myc higher activity (mRNA and protein stabilization, mi-RNA alteration, and so on) making difficult to infer the MYCN relevance in these cases (65, 66). The gene discussed is MYCN; the disease is cancer.